Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,6478724,Anxrr35,Anxiety related response QTL 35,,0.00449,defecation behavior trait (VT:0010462),defecation measurement (CMO:0000997),4,8052189,53052189,Rat,n/a,region,qtl 1000,6478766,Anxrr47,Anxiety related response QTL 47,,0.09637,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),4,8052189,53052189,Rat,n/a,region,qtl 1000,6478769,Anxrr48,Anxiety related response QTL 48,,0.02514,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,8052189,53052189,Rat,n/a,region,qtl 1000,1300141,Bp178,Blood pressure QTL 178,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,6572939,37703537,Rat,n/a,region,qtl 1000,2303168,Bp330,Blood pressure QTL 330,4.25,0.017,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,3043231,145254791,Rat,n/a,region,qtl 1000,619616,Bp79,Blood pressure QTL 79,,0.0292,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,3043231,79575658,Rat,n/a,region,qtl 1000,8694374,Bw155,Body weight QTL 155,3.39,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),4,8052189,53052189,Rat,n/a,region,qtl 1000,631209,Bw2,Body weight QTL2,4.2,,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),4,6467693,43414792,Rat,n/a,region,qtl 1000,2303585,Bw86,Body weight QTL 86,4,,body mass (VT:0001259),body weight (CMO:0000012),4,12638974,57638974,Rat,n/a,region,qtl 1000,1641905,Colcr1,Colorectal carcinoma resistance QTL 1,4.3,0.0003,intestine integrity trait (VT:0010554),benign colorectal tumor surface area measurement (CMO:0001799),4,1,26654881,Rat,n/a,region,qtl 1000,1358201,Gluco12,Glucose level QTL12,1.6,,adipocyte glucose uptake trait (VT:0004185),adipocyte maximal glucose uptake (CMO:0000870),4,3044114,26753655,Rat,n/a,region,qtl 1000,61333,Gluco16,Glucose level QTL 16,4.3,,adipocyte glucose uptake trait (VT:0004185),adipocyte maximal glucose uptake to basal glucose uptake ratio (CMO:0000874),4,1,26803291,Rat,n/a,region,qtl 1000,1357343,Gluco4,Glucose level QTL 4,3.1,,adipocyte glucose uptake trait (VT:0004185),adipocyte maximal glucose uptake to basal glucose uptake ratio (CMO:0000874),4,1,29778604,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,7850904,182171018,Rat,n/a,region,qtl 1000,634323,Hc2,Hypercalciuria QTL 2,2.15,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),4,1,42118977,Rat,n/a,region,qtl 1000,738021,Hcar13,Hepatocarcinoma resistance QTL 13,4.3,,liver integrity trait (VT:0010547),liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464),4,1,31554484,Rat,n/a,region,qtl 1000,8552903,Pigfal2,Plasma insulin-like growth factor 1 level QTL 2,7.3,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),4,1,28352196,Rat,n/a,region,qtl 1000,8552906,Pigfal3,Plasma insulin-like growth factor 1 level QTL 3,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),4,8052189,53052189,Rat,n/a,region,qtl 1000,724557,Plsm1,Polydactyly-luxate syndrome (PLS) morphotypes QTL 1,,0.0003,forelimb integrity trait (VT:0010562),front foot phalanges count (CMO:0001947),4,1,25545519,Rat,n/a,region,qtl 1000,9589046,Scfw2,Subcutaneous fat weight QTL 2,5.54,0.001,subcutaneous adipose mass (VT:1000472),abdominal subcutaneous fat pad weight (CMO:0002069),4,1,28352196,Rat,n/a,region,qtl 1000,61408,Scl23,Serum cholesterol level QTL 23,,0.0005,blood HDL phospholipid amount (VT:0010504),serum high density lipoprotein phospholipid level (CMO:0001567),4,1,25545519,Rat,n/a,region,qtl 1000,9590304,Scort17,Serum corticosterone level QTL 17,4.96,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,8052189,53052189,Rat,n/a,region,qtl 1000,9590100,Sffal4,Serum free fatty acids level QTL 4,7.36,0.05,blood free fatty acid amount (VT:0001553),plasma free fatty acids level (CMO:0000546),4,1,28352196,Rat,n/a,region,qtl 1000,9589097,Slep11,Serum leptin concentration QTL 11,5.09,0.001,blood leptin amount (VT:0005667),plasma leptin level (CMO:0000781),4,1,28352196,Rat,n/a,region,qtl 1000,1358203,Stl19,Serum triglyceride level QTL 19,2.8,0.002,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),4,3044017,64915903,Rat,n/a,region,qtl 1000,631642,Stl2,Serum triglyceride level QTL 2,3.3,,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),4,3047807,55324857,Rat,n/a,region,qtl 1000,2302371,Stl22,Serum triglyceride level QTL 22,5.15,,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),4,3044017,55791834,Rat,n/a,region,qtl 1000,631261,Tcas3,Tongue tumor susceptibility QTL 3,6.88,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),4,7342404,92484039,Rat,n/a,region,qtl 1000,7387227,Uae40,Urinary albumin excretion QTL 40,2.9,0.0052,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),4,16149941,61149941,Rat,n/a,region,qtl